Drozitumab Antibody
Drozitumab (PRO 95780) is a fully human anti-DR5 agonistic antibody that induces apoptosis. It has demonstrated anti-tumor activity in preclinical studies of rhabdomyosarcoma and is a research tool for investigating triple-negative breast cancer in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
Anti-Human DR5 Recombinant Antibody, PRO 95780, PRO95780, rhuMAb-DR 5, RG7425, RG 7425
Target
Apoptosis, TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.44 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.09 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx322125-01 20 µL
Beta-Adrenergic Receptor Kinase 1 (GRK2) Antibody
Sign In for Pricing
View Details abx322125-02 50 µL
Beta-Adrenergic Receptor Kinase 1 (GRK2) Antibody
Sign In for Pricing
View Details abx322125-03 100 µL
Beta-Adrenergic Receptor Kinase 1 (GRK2) Antibody
Sign In for Pricing
View Details